Academic Journal

Mitral valve‐in‐valve and valve‐in‐ring procedures: Midterm outcomes in a French nationwide registry

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Mitral valve‐in‐valve and valve‐in‐ring procedures: Midterm outcomes in a French nationwide registry
Συγγραφείς: Le Ruz, Robin, Guérin, Patrice, Leurent, Guillaume, Leroux, Lionel, Lefevre, Thierry, Nejjari, Mohammed, Champagnac, Didier, Tchétché, Didier, Lhermusier, Thibault, Senage, Thomas, Piriou, Pierre‐Guillaume, Caussin, Christophe, Delomez, Maxence, Bonnet, Guillaume, Favereau, Xavier, Karam, Nicole, Gerbay, Antoine, Juthier, Francis, Gilard, Martine, Obadia, Jean‐Francois, Iung, Bernard, Manigold, Thibaut
Πηγή: Catheterization and Cardiovascular Interventions ; volume 99, issue 6, page 1829-1838 ; ISSN 1522-1946 1522-726X
Στοιχεία εκδότη: Wiley
Έτος έκδοσης: 2022
Συλλογή: Wiley Online Library (Open Access Articles via Crossref)
Περιγραφή: Objectives Report contemporary outcomes in patients included in the Mitragister registry and treated with transcatheter mitral valve implantation for failed surgical annuloplasty rings or deteriorated bioprosthesis. Background Midterm survival rates have been reported, but little is known about contemporary morbimortality endpoints. Methods The primary safety outcome was the technical success rate. The primary efficacy composite endpoint was a composite of cardiovascular mortality and heart failure hospitalizations. Results From 2016 to 2021, 102 patients (median age: 81 [74;84] years, 61% female, Euroscore II 11.0% [7.8;16.0]) undergoing valve‐in‐valve (ViV; n = 89) or valve‐in‐ring (ViR; n = 13) procedures were consecutively included. At baseline, ViR group patients had worse left ventricular ejection fraction (50% vs. 60%; p = 0.004) and more frequently severe regurgitation (46% vs. 15%; p = 0.014). The primary safety outcome was 95%: 77% and 98% in the ViR and ViV populations, respectively, ( p = 0.014). At intermediate follow‐up (6–12 months) clinical improvement was notable, 88% of the patients were in NYHA class ≤ II (vs. 25% at baseline; p < 0.001). At a mean follow‐up of 17.1 ± 11.0 months, the primary efficacy composite reached 27%. By multivariate analysis, paravalvular leak (PVL) was the only independent predictor (hazard ratio: 2.39, 95% confidence interval: 1.08–5.29; p = 0.031) while ViR was not found statistically associated ( p = 0.456). Conclusions This study confirms the safety and efficacy of the mitral ViV procedure. ViR patients appear at higher risk of procedural complications. The presence of PVL could be associated with markedly worse midterm prognosis. Whatever the intervention, procedural strategies to reduce PVL incidence remain to be assessed to prevent latter adverse outcomes.
Τύπος εγγράφου: article in journal/newspaper
Γλώσσα: English
DOI: 10.1002/ccd.30161
Διαθεσιμότητα: https://doi.org/10.1002/ccd.30161
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30161
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ccd.30161
Rights: http://onlinelibrary.wiley.com/termsAndConditions#vor
Αριθμός Καταχώρησης: edsbas.F1539F13
Βάση Δεδομένων: BASE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://doi.org/10.1002/ccd.30161#
    Name: EDS - BASE (ns324271)
    Category: fullText
    Text: View record from BASE
Header DbId: edsbas
DbLabel: BASE
An: edsbas.F1539F13
RelevancyScore: 920
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 920.2763671875
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mitral valve‐in‐valve and valve‐in‐ring procedures: Midterm outcomes in a French nationwide registry
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Le+Ruz%2C+Robin%22&quot;&gt;Le Ruz, Robin&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gu&#233;rin%2C+Patrice%22&quot;&gt;Gu&#233;rin, Patrice&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Leurent%2C+Guillaume%22&quot;&gt;Leurent, Guillaume&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Leroux%2C+Lionel%22&quot;&gt;Leroux, Lionel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lefevre%2C+Thierry%22&quot;&gt;Lefevre, Thierry&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Nejjari%2C+Mohammed%22&quot;&gt;Nejjari, Mohammed&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Champagnac%2C+Didier%22&quot;&gt;Champagnac, Didier&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tch&#233;tch&#233;%2C+Didier%22&quot;&gt;Tch&#233;tch&#233;, Didier&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lhermusier%2C+Thibault%22&quot;&gt;Lhermusier, Thibault&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Senage%2C+Thomas%22&quot;&gt;Senage, Thomas&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Piriou%2C+Pierre‐Guillaume%22&quot;&gt;Piriou, Pierre‐Guillaume&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Caussin%2C+Christophe%22&quot;&gt;Caussin, Christophe&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Delomez%2C+Maxence%22&quot;&gt;Delomez, Maxence&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bonnet%2C+Guillaume%22&quot;&gt;Bonnet, Guillaume&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Favereau%2C+Xavier%22&quot;&gt;Favereau, Xavier&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Karam%2C+Nicole%22&quot;&gt;Karam, Nicole&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gerbay%2C+Antoine%22&quot;&gt;Gerbay, Antoine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Juthier%2C+Francis%22&quot;&gt;Juthier, Francis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gilard%2C+Martine%22&quot;&gt;Gilard, Martine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Obadia%2C+Jean‐Francois%22&quot;&gt;Obadia, Jean‐Francois&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Iung%2C+Bernard%22&quot;&gt;Iung, Bernard&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Manigold%2C+Thibaut%22&quot;&gt;Manigold, Thibaut&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Catheterization and Cardiovascular Interventions ; volume 99, issue 6, page 1829-1838 ; ISSN 1522-1946 1522-726X
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Wiley
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2022
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: Wiley Online Library (Open Access Articles via Crossref)
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Objectives Report contemporary outcomes in patients included in the Mitragister registry and treated with transcatheter mitral valve implantation for failed surgical annuloplasty rings or deteriorated bioprosthesis. Background Midterm survival rates have been reported, but little is known about contemporary morbimortality endpoints. Methods The primary safety outcome was the technical success rate. The primary efficacy composite endpoint was a composite of cardiovascular mortality and heart failure hospitalizations. Results From 2016 to 2021, 102 patients (median age: 81 [74;84] years, 61% female, Euroscore II 11.0% [7.8;16.0]) undergoing valve‐in‐valve (ViV; n = 89) or valve‐in‐ring (ViR; n = 13) procedures were consecutively included. At baseline, ViR group patients had worse left ventricular ejection fraction (50% vs. 60%; p = 0.004) and more frequently severe regurgitation (46% vs. 15%; p = 0.014). The primary safety outcome was 95%: 77% and 98% in the ViR and ViV populations, respectively, ( p = 0.014). At intermediate follow‐up (6–12 months) clinical improvement was notable, 88% of the patients were in NYHA class ≤ II (vs. 25% at baseline; p &lt; 0.001). At a mean follow‐up of 17.1 &#177; 11.0 months, the primary efficacy composite reached 27%. By multivariate analysis, paravalvular leak (PVL) was the only independent predictor (hazard ratio: 2.39, 95% confidence interval: 1.08–5.29; p = 0.031) while ViR was not found statistically associated ( p = 0.456). Conclusions This study confirms the safety and efficacy of the mitral ViV procedure. ViR patients appear at higher risk of procedural complications. The presence of PVL could be associated with markedly worse midterm prognosis. Whatever the intervention, procedural strategies to reduce PVL incidence remain to be assessed to prevent latter adverse outcomes.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article in journal/newspaper
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1002/ccd.30161
– Name: URL
  Label: Availability
  Group: URL
  Data: https://doi.org/10.1002/ccd.30161&lt;br /&gt;https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30161&lt;br /&gt;https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ccd.30161
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: http://onlinelibrary.wiley.com/termsAndConditions#vor
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsbas.F1539F13
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.F1539F13
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ccd.30161
    Languages:
      – Text: English
    Titles:
      – TitleFull: Mitral valve‐in‐valve and valve‐in‐ring procedures: Midterm outcomes in a French nationwide registry
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Le Ruz, Robin
      – PersonEntity:
          Name:
            NameFull: Guérin, Patrice
      – PersonEntity:
          Name:
            NameFull: Leurent, Guillaume
      – PersonEntity:
          Name:
            NameFull: Leroux, Lionel
      – PersonEntity:
          Name:
            NameFull: Lefevre, Thierry
      – PersonEntity:
          Name:
            NameFull: Nejjari, Mohammed
      – PersonEntity:
          Name:
            NameFull: Champagnac, Didier
      – PersonEntity:
          Name:
            NameFull: Tchétché, Didier
      – PersonEntity:
          Name:
            NameFull: Lhermusier, Thibault
      – PersonEntity:
          Name:
            NameFull: Senage, Thomas
      – PersonEntity:
          Name:
            NameFull: Piriou, Pierre‐Guillaume
      – PersonEntity:
          Name:
            NameFull: Caussin, Christophe
      – PersonEntity:
          Name:
            NameFull: Delomez, Maxence
      – PersonEntity:
          Name:
            NameFull: Bonnet, Guillaume
      – PersonEntity:
          Name:
            NameFull: Favereau, Xavier
      – PersonEntity:
          Name:
            NameFull: Karam, Nicole
      – PersonEntity:
          Name:
            NameFull: Gerbay, Antoine
      – PersonEntity:
          Name:
            NameFull: Juthier, Francis
      – PersonEntity:
          Name:
            NameFull: Gilard, Martine
      – PersonEntity:
          Name:
            NameFull: Obadia, Jean‐Francois
      – PersonEntity:
          Name:
            NameFull: Iung, Bernard
      – PersonEntity:
          Name:
            NameFull: Manigold, Thibaut
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-locals
              Value: edsbas
            – Type: issn-locals
              Value: edsbas.oa
          Titles:
            – TitleFull: Catheterization and Cardiovascular Interventions ; volume 99, issue 6, page 1829-1838 ; ISSN 1522-1946 1522-726X
              Type: main
ResultId 1